Pacira Pharmaceuticals shares owned by Simplex Trading
Quarter-by-quarter ownership of Pacira Pharmaceuticals shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pacira Pharmaceuticals by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $207k | 14k | 15.00 |
| 2024-06-30 | $260k | 9.1k | 28.57 |
| 2024-03-31 | $55k | 1.9k | 28.95 |
| 2023-12-31 | $1.5M | 44k | 33.74 |
| 2023-09-30 | $352k | 12k | 30.61 |
| 2023-06-30 | $180k | 4.5k | 40.00 |
| 2023-03-31 | $44k | 1.1k | 40.00 |
| 2022-12-31 | $274k | 7.1k | 38.59 |
| 2022-09-30 | $196k | 3.7k | 52.97 |
| 2022-06-30 | $134k | 2.3k | 58.26 |
| 2022-03-31 | $99k | 1.3k | 76.15 |
| 2021-12-31 | $41k | 700 | 58.57 |
| 2021-09-30 | $41k | 700 | 58.57 |
| 2021-06-30 | $42k | 700 | 60.00 |
| 2021-03-31 | $56 | 8 | 7.00 |
| 2020-12-31 | $71 | 12 | 5.92 |
| 2020-09-30 | $60 | 10 | 6.00 |
| 2020-06-30 | $214 | 41 | 5.24 |
| 2020-03-31 | $63 | 19 | 3.32 |
| 2019-12-31 | $207 | 46 | 4.52 |
| 2019-09-30 | $1.4k | 359 | 3.81 |
| 2019-06-30 | $835 | 192 | 4.35 |
| 2019-03-31 | $26 | 7 | 3.71 |
| 2018-12-31 | $193 | 45 | 4.29 |
| 2018-09-30 | $776 | 158 | 4.91 |
| 2018-06-30 | $54 | 17 | 3.18 |
| 2018-03-31 | $0 | 37 | 0.00 |
| 2017-12-31 | $133k | 189 | 703.70 |
| 2017-09-30 | $1.0k | 18 | 55.56 |
| 2017-03-31 | $199k | 311 | 639.87 |
| 2016-12-31 | $0 | 12 | 0.00 |
| 2016-09-30 | $7.0k | 107 | 65.42 |
| 2016-06-30 | $3.0k | 25 | 120.00 |
| 2016-03-31 | $9.0k | 27 | 333.33 |
| 2015-12-31 | $66k | 228 | 289.47 |
| 2015-09-30 | $11k | 274 | 40.15 |
| 2015-06-30 | $2.0k | 26 | 76.92 |
| 2015-03-31 | $14k | 58 | 241.38 |
| 2014-12-31 | $30k | 50 | 600.00 |
Top funds holding Pacira Pharmaceuticals
View all funds holding Pacira Pharmaceuticals